Skip to content

The Effect of Arginine on Biofilm Composition, Architecture and Metabolism

The Effect of Arginine on Biofilm Composition, Architecture and Metabolism in Caries-active Patients: a Split-mouth in Situ Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06135792
Enrollment
12
Registered
2023-11-18
Start date
2023-10-19
Completion date
2024-02-13
Last updated
2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Dental Plaque, Microbial Colonization

Brief summary

Arginine is an adjunct to oral health care that has the potential to modulate the composition and activity of the microbial community of dental biofilms towards a health-related status without harmful effects for the resident oral microbiota. The aim of the study is to investigate the effects of arginine treatment compared to placebo on the composition, metabolism, and microarchitecture of biofilms grown in situ in the oral cavity of caries-active participants.

Interventions

OTHERArginine

See arm description

OTHERPlacebo

See arm description

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Split-mouth design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females ≥ 18 years old. * Three or more active carious lesions. * Anatomically possible to manufacture an intraoral lower-jaw splint. * Able to understand and follow instructions, as well as to read and sign the informed consent form.

Exclusion criteria

* History of allergies towards any of the ingredients in the test products * Self-reported pregnant or nursing * Antibiotic or anti-inflammatory medication within 90 days of the screening visit. * Orthodontic appliances, including retainers, or removable partial dentures. * Self-reported serious medical conditions.

Design outcomes

Primary

MeasureTime frameDescription
Biofilm pHMeasured after in situ biofilm growthExtracellular biofilm pH measured after sucrose challenge using pH ratiometry

Secondary

MeasureTime frameDescription
Biofilm microbial compositionAnalyzed after in situ biofilm growthMicrobial community of dental biofilms determined by 16S rRNA gene sequencing. Distribution of specific microbial targets in the biofilms is visualized by fluorescence in situ hybridization.
Biofilm matrix architectureAnalyzed after of in situ biofilm growthMatrix components are visualized in the dental biofilms by confocal microscopy.
Biofilm thicknessMeasured after in situ biofilm growthMeasured using confocal laser scanning microscopy and/or optical coherence tomography.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026